Los Angeles, CA -- (SBWIRE) -- 05/14/2019 -- Astragaloside IV extract from astragalus Root.
Astragaloside iv can increase energy and endurance, It has the function of enhancing immunity, protecting the body from diseases such as cancer and diabetes,and aid in the recovery from chronic stress or prolonged illness.
The global Astragaloside IV market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Astragaloside IV volume and value at global level, regional level and company level. From a global perspective, this report represents overall Astragaloside IV market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Access PDF version of this report at: https://www.qyresearch.com/sample-form/form/1001355/global-astragaloside-iv-industry-chain-research-report-
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
NandR Bio Industries
Zenergy Korea Corporation
Wuhan Vanz Pharm
Shaanxi Pioneer Biotech
Xi'an Lyphar Biotech
Xian Pincredit Bio-Tech
Shaanxi Fuheng (FH) Biotechnology
Segment by Regions
Segment by Type
Segment by Application
Get this report now at USD 2,900 : https://www.qyresearch.com/settlement/pre/e43703bc3c1b39a5995ae7f2f6221c42,0,1,Global%20Astragaloside%20IV%20Industry%20Chain%20Research%20Report%202019
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.